Alissa Marrapodi is Industry Insights Contributor, Custom Content Editor, MJH Life Sciences.
FDA issues warning letters to sellers of supplements marketed as hangover cures
August 6th 2020FDA issued warning letters to seven companies for illegally selling unapproved products labeled as dietary supplements that claim to cure, treat, mitigate, or prevent hangovers, in violation of the Federal Food, Drug, and Cosmetic Act.
Lief Labs announces commitment to support Vitamin Angels’ Healthy Futures Initiative
July 30th 2020Lief Labs made a commitment to support Vitamin Angels’ Healthy Futures Initiative, a unified effort working to raise $500,000 to address the long-term impacts of COVID-19 on vulnerable communities in the United States and globally.
New AI-based system, MedicascyAI, predicts where ingredients will have significant impact
July 28th 2020Medicascy Artificial Intelligence Solutions Platform is a new technology that uses artificial intelligence to predict, in just a few weeks, where ingredients will have significant impact, cutting research and development time while improving the product.
Valensa awarded patent for hyaluronic acid, astaxanthin joint ingredients
July 14th 2020The United States Patent and Trademark Office awarded Patent No. 10,624,919 to Valensa International for the “Composition and Method to Alleviate Joint Pain Using Low Molecular Weight Hyaluronic Acid and Astaxanthin."
New BAPP bulletin summarizes info on adulteration of English lavender oil
July 9th 2020Although the safety and efficacy of authentic English lavender oil have been documented in published clinical trials, due to the comparatively high cost of English lavender essential oil, substitution with other, lower-cost species of Lavandula has been reported.